Human Antibodies Targeting Influenza B Virus Neuraminidase Active Site Are Broadly Protective

Influenza B virus (IBV) infections can cause severe disease in children and the elderly. Commonly used antivirals have lower clinical effectiveness against IBV compared to influenza A viruses (IAV). Neuraminidase (NA), the second major surface protein on the influenza virus, is emerging as a target...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Immunity
Autors principals: Madsen, Anders, Dai, Ya-Nan, McMahon, Meagan, Schmitz, Aaron J., Turner, Jackson S., Tan, Jessica, Lei, Tingting, Alsoussi, Wafaa B., Strohmeier, Shirin, Amor, Mostafa, Mohammed, Bassem M., Mudd, Philip A., Simon, Viviana, Cox, Rebecca J., Fremont, Daved H., Krammer, Florian, Ellebedy, Ali H.
Format: Artigo
Idioma:Inglês
Publicat: 2020
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7572813/
https://ncbi.nlm.nih.gov/pubmed/32976769
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.immuni.2020.08.015
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars